Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXYBUTYNIN for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 7 adverse event reports in the FDA FAERS database where OXYBUTYNIN was used for Psoriasis.

Most Reported Side Effects for OXYBUTYNIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 1,784 22.9% 1 148
Dry mouth 519 6.7% 3 47
Application site erythema 395 5.1% 0 0
Off label use 385 5.0% 1 124
Constipation 379 4.9% 3 152
Product adhesion issue 336 4.3% 0 1
Headache 334 4.3% 1 144
Erythema 315 4.1% 0 112
Nausea 308 4.0% 1 136
Application site pruritus 289 3.7% 0 1
Dizziness 281 3.6% 2 47
Pruritus 277 3.6% 3 7
Product use issue 254 3.3% 1 1
Pain 250 3.2% 2 133
Rash 240 3.1% 1 7

Other Indications for OXYBUTYNIN

Product used for unknown indication (2,976) Hypertonic bladder (1,644) Urinary incontinence (581) Pollakiuria (297) Incontinence (232) Micturition urgency (190) Bladder disorder (177) Bladder spasm (81) Nocturia (81) Enuresis (63)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

OXYBUTYNIN Full Profile All Psoriasis Drugs OXYBUTYNIN Demographics OXYBUTYNIN Timeline